Silicon Valley Capital Partners Ark Genomic Revolution ETF (De Transaction History

Silicon Valley Capital Partners

  • $670 Million
  • Q1 2024

A detailed history of Silicon Valley Capital Partners transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Silicon Valley Capital Partners holds 62 shares of ARKG stock, worth $1,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62
Previous 62 -0.0%
Holding current value
$1,435
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$27.08 - $36.23 $1,678 - $2,246
62 New
62 $1,000

Others Institutions Holding ARKG

# of Institutions
318
Shares Held
19.1M
Call Options Held
1.49M
Put Options Held
2.83M
View Full List

About ARK GENOMIC REVOLUTION ETF (DE

ARKG Quotes by TradingView
  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Silicon Valley Capital Partners Portfolio

Follow Silicon Valley Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Valley Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Valley Capital Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email